Meticulous Research® recently released a comprehensive report titled ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive), Offering (Analyzer, Software), Technology (Chemiluminescence, Colorimetry, Fluorescence), Application (Research, Diagnostic), End User—Global Forecast to 2031. The report details the growth, trends, and projections for the ELISA (enzyme-linked immunosorbent assay) market, which is anticipated to reach $32.69 billion by 2031, expanding at a 6.1% CAGR from 2024 to 2031.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5997?
Growth Drivers and Challenges
The ELISA market’s growth is largely fueled by the rising burden of chronic and infectious diseases, an expanding scope of ELISA applications in clinical settings, technological advancements in ELISA methods, and increased use of ELISA across the food industry. However, obstacles like the potential for false positive results and high antibody preparation costs are expected to limit market expansion. Despite these challenges, growing research in emerging markets, a focus on biomarker research, and an emphasis on vaccine development are creating new opportunities. On the other hand, stringent regulations for alternative diagnostic technologies present a significant hurdle for the industry.
